Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant

Completed · Not applicable

Conditions studied: Hyperglycemia, Malignant Neoplasm

In brief

This clinical trial studies computer-guided glucose management systems in treating patients with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided glucose management system may help manage glucose levels in patients who have undergone blood or bone marrow transplant.

Key facts

Study ID

NCT01236885

Run by

Fred Hutchinson Cancer Center

People needed

19

Starts

2012-12-01

Last updated by the study team

2015-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Post-transplant adult patients (age >= 18 years) on the BMT Service at UWMC
• Requiring insulin secondary to:
• Known history of (h/o) type 2 diabetes mellitus
• Two blood sugar values > 180 (point of care and/or am lab glycemia)
• One blood sugar value > 250 (point of care or AM lab glycemia)

You may not qualify if…

• Critically ill patients (intensive care unit [ICU] admissions)
• Terminally ill patients
• Eastern Cooperative Oncology Group (ECOG) performance status > 3
• Previous type 1 diabetes mellitus
• Cognitively impaired patients, unable to consent

Where it is running

• Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
• Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.